EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mast Cell Association with the Microenvironment of a Phosphaturic Mesenchymal Tumour Secreting Fibroblast Growth Factor 23

Andrey Kostin, Alexei Lyundup, Alexander Alekhnovich, Aleksandra Prikhodko, Olga Patsap, Sofia Gronskaia, Zhanna Belaya iD, Olga Lesnyak iD, Galina Melnichenko, Natalia Mokrysheva, Igor Buchwalow iD, Markus Tiemann iD und 1 weitere

Medical Sciences · 16.09.2025 · 13 (3) · 195

DOI: 10.3390/medsci13030195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 16.09.2025. Verfasst von Andrey Kostin und 12 weiteren Autor:innen. Beteiligte Einrichtung: RUDN University, 6 Miklukho-Maklaya St., 117198 Moscow, Russia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Mast Cells, Fibroblast Growth Factors, Mesenchymoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RUDN University Scientific Projects Grant System., RUDN University Scientific Projects Grant System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phosphaturic mesenchymal tumours secreting fibroblast growth factor 23 (hereinafter referred to as FGF23+ PMT) are rare neoplasms that can cause hypophosphataemic osteomalacia, owing to excessive FGF23 production. Mast cells (MCs) play a key role in tumour biology by modulating proliferative activity of atypical cells, resistance to innate and acquired immunity, angiogenesis, and metastatic behaviour. However, MCs associated with FGF23+ PMT have not previously been investigated. This study, to our knowledge, is the first to characterise features of the tumour microenvironment through spatial phenotyping of the immune and stromal landscape, together with histotopographic mapping of intercellular MC interactions with other subcellular populations in FGF23+ PMT.

Methods

Histochemical staining (haematoxylin and eosin, toluidine blue, Giemsa solution, picro-Mallory protocol, silver impregnation), as well as monoplex and multiplex immunohistochemical staining with spatial phenotyping, were performed to detect atypical FGF23-secreting cells, immune cells (CD3, CD4, CD8, CD14, CD20, CD38, CD68, or CD163), stromal components (CD31, α-SMA, or vimentin), and specific MC proteases (tryptase, chymase, or carboxypeptidase A3). Bioinformatics analysis using artificial intelligence technologies was applied for spatial profiling of MC interactions with tumour, immunocompetent, and stromal cells in the tumour microenvironment.

Results

Bioinformatic analysis of the entire tumour histological section, comprising over 70,000 cells stained using monoplex and multiplex immunohistochemical protocols, enabled identification of more than half of the cell population. The most abundant were CD14+ (30.7%), CD163+ (23.2%), and CD31+ (17.9%) cells. Tumour-associated MCs accounted for 0.7% of the total pool of immunopositive cells and included both mucosal and connective tissue subpopulations, predominantly of the tryptase + chymase-CPA3-specific protease phenotype. This pattern reflected combined multidirectional morphogenetic processes in the patient’s FGF23+ PMT. More than 50% of MCs were colocalized with neighbouring cells of the tumour microenvironment within 20 μm, most frequently with monocytes (CD14+CD68+), M2 macrophages (CD68+CD163+), and endothelial cells (CD31+). In contrast, colocalization with atypical FGF23-secreting cells was rare, indicating minimal direct effects on tumour cell activity. Interaction with T lymphocytes, including CD8+, was also infrequent, excluding their activation and the development of antitumour effects. Mapping of MC histotopography validated the hypothesis of their inductive role in monocyte differentiation into M2 macrophages and probable polarisation of macrophages from M1 into M2, thereby contributing to slow tumour growth. MCs were further involved in extracellular matrix remodelling and participated in the formation of pro-osteogenic niches within the FGF23+ PMT microenvironment, leading to pathological osteoid development.

Conclusions

This study demonstrated active MC participation in the evolution of the FGF23+ PMT microenvironment. The findings may be applied in translational medicine to develop novel algorithms for personalised therapy in patients with FGF23-secreting tumours, offering an alternative when surgical removal of the tumour is not feasible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentMast CellsFibroblast Growth FactorsMesenchymomaHumansFibroblast Growth Factor-23FemaleMaleMiddle AgedNeoplasms, Connective Tissue

Stichwörter der Autor:innen

carboxypeptidase A3chymaseextracellular matriximmune landscapeintercellular interactionmast cellsmultiplex immunohistochemistryphosphaturic mesenchymal FGF23-secreting tumourspatial phenotypingtryptasetumour microenvironment

Substanzen

Fibroblast Growth Factor-23FGF23 protein, humanFibroblast Growth Factors

Autor:innen und Institutionen

  • RUDN University, 6 Miklukho-Maklaya St., 117198 Moscow, Russia.
  • Endocrinology Research Center, Dm. Ulyanova St. 11, 117292 Moscow, Russia.
  • North-West State Medical University, 191015 Saint-Petersburg, Russia.
  • Institute for Hematopathology, Fangdieckstr. 75a, 22547 Hamburg, Germany.

ORCID-Profile: Zhanna Belaya, Olga Lesnyak, Igor Buchwalow, Markus Tiemann, Dmitrii Atiakshin

Förderung

  • RUDN University Scientific Projects Grant System.
  • RUDN University Scientific Projects Grant System

Zitieren

APA

Kostin, A., Lyundup, A., Alekhnovich, A., Prikhodko, A., Patsap, O., Gronskaia, S., Belaya, Z., Lesnyak, O., Melnichenko, G., Mokrysheva, N., Buchwalow, I., Tiemann, M., & Atiakshin, D. (2025). Mast Cell Association with the Microenvironment of a Phosphaturic Mesenchymal Tumour Secreting Fibroblast Growth Factor 23. Medical Sciences, 13(3), 195. https://doi.org/10.3390/medsci13030195

Vancouver

Kostin A, Lyundup A, Alekhnovich A, Prikhodko A, Patsap O, Gronskaia S, et al. Mast Cell Association with the Microenvironment of a Phosphaturic Mesenchymal Tumour Secreting Fibroblast Growth Factor 23. Medical Sciences. 2025;13(3):195. doi:10.3390/medsci13030195

BibTeX
@article{Kostin2025,
  author = {Kostin, Andrey and Lyundup, Alexei and Alekhnovich, Alexander and Prikhodko, Aleksandra and Patsap, Olga and Gronskaia, Sofia and Belaya, Zhanna and Lesnyak, Olga and Melnichenko, Galina and Mokrysheva, Natalia and Buchwalow, Igor and Tiemann, Markus and Atiakshin, Dmitrii},
  title = {Mast Cell Association with the Microenvironment of a Phosphaturic Mesenchymal Tumour Secreting Fibroblast Growth Factor 23},
  journal = {Medical Sciences},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {195},
  doi = {10.3390/medsci13030195}
}
Kostenlos starten →